Five ways Medicine by Design is transforming the treatment of liver disease
Medicine by Design-funded researchers are leading the way in ground-breaking liver research
Pioneering patient-guided study helps map rare liver disease
Innovative study unveils rare liver disease secrets
Medicine by Design-funded researchers generate cells that will impact treatments for bile duct disorders as a result of cystic fibrosis
Newly-generated cells may lead to a deeper understanding of bile duct disease and be a powerful tool for finding new treatments.
New Medicine by Design-funded method for testing muscle repair in a dish to impact development of stem cell-based therapies
Scientists at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, a method with the potential to accelerate treatments for diseases like muscular dystrophy.
Growing mini-organs to study brain development and disease
This “revolutionizing biology” offers the promise of new treatments for diseases and conditions including inflammatory bowel disease and autism spectrum disorder.
Cycle 2 Discussion Group: How are stemness properties of blood relevant for cell replacement therapies?
Medicine by Design is launching a new discussion group series to provide an opportunity for investigators and trainees from Cycle 2 projects to connect with each other, discuss overlapping interests, and share information about the development and implementation of new technologies and tools that could be applicable to multiple projects. Each session will feature two speakers from Cycle 2 projects, followed by a group discussion.
Advancing stem cell manufacturing technologies
Cross-cutting research makes promising strides toward clinical testing
New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours
Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.
Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
Cycle 2 Discussion Group: Applying single-cell RNA sequencing technologies to your research
Medicine by Design is launching a new discussion group series to provide an opportunity for investigators [...]
Better outcomes in treating blindness
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.
Harnessing the liver’s power to regenerate
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.
Using stem cells to prevent heart failure
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.
Medicine by Design-funded researchers develop cell injection technique that could help reverse vision loss
The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated